Alcohol, tobacco and cannabis use among Spanish students aged 14–18 hits historic lows

Feb.09
Alcohol, tobacco and cannabis use among Spanish students aged 14–18 hits historic lows
Spain’s 2025 Survey on Drug Use in Secondary Education (ESTUDES), presented by the Ministry of Health, reports historic lows in alcohol, tobacco and cannabis consumption among students aged 14 to 18. The survey shows past-30-day drinking fell from 56.6% in 2023 to 51% in 2025, tobacco use from 21.0% to 15.5%, and cannabis use from 15.5% to 11.6%.

 

Key Takeaways

 

  • Survey: ESTUDES 2025, tracking adolescent drug use in Spain since 1994
  • Past 30 days (2025 vs 2023): alcohol 51% vs 56.6%; tobacco 15.5% vs 21.0%; cannabis 11.6% vs 15.5%
  • Binge drinking: 24.7%, cited as the lowest since measurement began
  • E-cigarettes: past-30-day use 27.1% vs 26.3%; past-year and lifetime measures down versus 2023
  • Sample: 35,256 students across 1,658 classrooms and 836 schools

 

 


 

 

 

2Firsts, Feb 9 2026

 

According to MundoAmerica, Spain’s Ministry of Health presented results from the 2025 Survey on Drug Use in Secondary Education (ESTUDES), reporting historic lows in alcohol, tobacco and cannabis consumption among students aged 14 to 18. The survey has tracked adolescent habits and drug use since 1994.

 

The report says Health Minister Mónica García and the Government Delegate of the National Drug Plan Xisca Sureda stated that in 2025, consumption of all psychoactive substances analysed has decreased or stabilised. García said “the new generations are changing and building a new way of understanding leisure and health.”

 

Based on the figures cited, past-30-day alcohol use fell from 56.6% (2023) to 51% (2025). Past-30-day tobacco use fell from 21.0% to 15.5%, described as the lowest figure recorded. Past-30-day cannabis use fell from 15.5% to 11.6%.

 

The report also says that compared with 1998, past-30-day alcohol consumption is 17 percentage points lower, tobacco is down more than 15 points, and cannabis is nearly 14 points below its historical peak in 2004. Binge drinking declined to 24.7%, which García described as “the lowest value since this type of consumption has been measured,” and she said the survey also shows an increase in perceived risks associated with drugs.

 

On e-cigarettes, Sureda was quoted as noting a slight increase in past-30-day use to 27.1% in 2025 from 26.3% in 2023, while measures of past-year and lifetime use declined compared with the previous survey.

 

The report says the 2025 survey involved 35,256 students from 1,658 classrooms and 836 centres across Spain.

 

Alcohol remains the most consumed legal drug among young people, the report says. It cites ESTUDES figures showing 73.9% of students reported lifetime alcohol use (vs 75.9% in 2023), 71.0% reported use in the past 12 months (vs 73.6%), and 51.8% reported use in the past 30 days (vs 56.6%). The average age of initiation remains 13.9 years, while weekly use and first drunkenness are reported at 14.8 and 14.6 years. García said that despite the historic lows, the figures “remain concerning,” and she and Sureda said it is “essential” for the Alcohol and Minors Law, expected to reach Congress soon, to move forward.

 

Tobacco use continues to decline, the report says. It cites figures of 27.3% lifetime smoking (vs 33.4% in 2023), 21.2% past-12-month use (vs 27.7%), and 15.5% past-30-day use (vs 21.0%). Daily smoking in the past month fell to 4.3%, down 3.2 percentage points from 7.5% in 2023. The average initiation age is 14.1 years, and starting daily smoking is 14.4 years. The report adds that the most common form combines packet cigarettes and roll-ups, and 46.4% of smokers attempted to quit in the past year.

 

Cannabis recorded one of the most significant decreases, Sureda said, according to the report. While it remains the most prevalent illegal substance, use declined across all timeframes: 21.0% lifetime (vs 26.9%), 15.5% past 12 months (vs 21.8%), and 11.6% past 30 days (vs 15.6%). The average age of initiation is 14.8 years, a tenth lower than the previous edition.

 

The report also cites a decline in lifetime use of hypnotics (tranquilizers and sleeping pills, with or without prescription) to 17.9%, described as the first decrease since 2014, with an average initiation age of 14 years. It adds that lower-prevalence substances such as hallucinogens, amphetamines, cocaine, heroin, MDMA and volatile inhalants also declined, including lifetime cocaine use down to 1.6% (vs 2.6% in 2023), hallucinogens at 1.4%, and volatile inhalants at 2.0%.

 

On risk perception, the report cites that perceived risk from habitual cannabis use reached the highest value in the ESTUDES series (94.1%). It also cites perceived risk of excessive weekend drinking at 67.6%, daily alcohol use at 66.2%, and that 93.3% of students believe daily smoking poses a high health risk.

 

Sureda said the historic low levels reflect a continued downward trend also seen in other European countries, the report says, attributing the decrease to prevention laws and interventions. García said “policies work” and that the government will continue working to create smoke- and alcohol-free environments.

 

Image Source: MundoAmerica

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Foreign Tobacco Registration Proposal Could Strengthen ENDS Import Oversight, Azim Chowdhury Says
FDA Foreign Tobacco Registration Proposal Could Strengthen ENDS Import Oversight, Azim Chowdhury Says
FDA’s proposed rule requiring foreign tobacco manufacturers to register establishments and list products is more than routine paperwork, Keller and Heckman LLP partner Azim Chowdhury told 2Firsts. He said it could strengthen FDA’s import enforcement, inspections and market surveillance. Chinese e-cigarette OEM/ODM manufacturers, specification developers, brand owners and component suppliers may need to review their roles, product data and U.S. market authorization status.
Special Report
Jun.29
NielsenIQ and Goldman Sachs Data Show Smokeless Was the Only Growing Major U.S. Nicotine Category
NielsenIQ and Goldman Sachs Data Show Smokeless Was the Only Growing Major U.S. Nicotine Category
NielsenIQ and Goldman Sachs data show U.S. smokeless nicotine product sales rose more than 8% year over year in the 52 weeks ended May 30, making it the only major nicotine category to record growth.
Market
Jun.23
Germany Seizes 56 Pallets of Illegal Vapes, Probe Estimates €1.8 Million Tax Loss
Germany Seizes 56 Pallets of Illegal Vapes, Probe Estimates €1.8 Million Tax Loss
German authorities have seized dozens of pallets of illegal disposable vapes in a criminal investigation, with the products estimated to have caused at least €1.8 million in tax losses. The case has also raised concerns over cross-border supply chains linked to unauthorized nicotine products entering the European market.
Jul.14
Kaival Brands Explores Nicotine Pouches as Smaller Nicotine Companies Seek Smoke-Free Growth
Kaival Brands Explores Nicotine Pouches as Smaller Nicotine Companies Seek Smoke-Free Growth
U.S. nicotine company Kaival Brands Innovations Group is exploring opportunities in nicotine pouches and other modern nicotine products, reflecting a broader shift among smaller nicotine businesses beyond traditional vaping products.
Jul.17
PMI Q2 Call: ZYN Growth, IQOS Pricing and a Diverging Global Tobacco Market
PMI Q2 Call: ZYN Growth, IQOS Pricing and a Diverging Global Tobacco Market
Philip Morris International’s second-quarter earnings call offered new detail on its smoke-free strategy. Management said it would increase U.S. investment behind nicotine pouch brand ZYN, keep IQOS focused on volume before stronger pricing, and use SENTIA, DELIA, LEVIA, VEEV and ZYN to manage tax and regulatory pressure across Japan and Europe. Analysts from Goldman Sachs, Morgan Stanley, UBS and other firms also pressed PMI on profitability, market share, cigarette resilience and the durability of its global transformation over coming quarters.
Jul.24
Global Tobacco Control Faces Regional Adaptation Test as Nicotine Markets Evolve, Asian Specialist Says
Global Tobacco Control Faces Regional Adaptation Test as Nicotine Markets Evolve, Asian Specialist Says
As e-cigarettes, heated tobacco products and nicotine pouches expand across global markets, a central question is gaining urgency: can tobacco control rely on a universal policy model? In an interview with 2Firsts, Asian public health and addiction medicine specialist Dr. Rashidi Mohamed bin Pakri Mohamed says Western experience remains relevant, but policies must be adapted to local culture, healthcare systems, enforcement capacity, illicit markets and clinical evidence.
Jul.08